An Open Label Study to Evaluate the Safety and Efficacy of BOR15001L7 for the Treatment of Cold Sores in Patients With Recurrent Herpes Labialis

PHASE2UnknownINTERVENTIONAL

Enrollment

164

Participants

Timeline

Start Date

September 30, 2020

Primary Completion Date

July 31, 2021

Study Completion Date

July 31, 2022

Conditions

Recurrent Herpes Labialis

Interventions

DRUG

BOR15001L7

BOR15001L7 topically applied to infected area, 5 times a day, until complete healing of the infection.

DRUG

Docosanol Cream 10%

Comparator product topically applied to infected area, 5 times a day, until complete healing of the infection.